New Berlin 6-Year-Old First in U.S. to Get Breakthrough Brain Drug at Children’s Wisconsin
Children’s Wisconsin has become the first U.S. hospital to treat a child with Avlayah, a newly FDA‑approved brain‑penetrant therapy for Hunter syndrome. The hospital started infusions for a 6‑year‑old from New Berlin this week.












